• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Formulary
    • Exclusives
    • Top Companies
    • Raw Materials
    • End-User
    • Packaging
    • Directories
    • Events
    • Jobs
    • More
  • Magazine
  • News
  • Formulary
  • Exclusives
  • Top Companies
  • Raw Materials
  • End-User
  • Packaging
  • Directories
  • Events
  • Jobs
  • Current / Back Issues
    Features
    Columns
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Stepping into the Spotlight for 2021

    The Independent Beauty Association Supports Sensible Reform

    Essential Workers

    A Clean Commitment

    Deliver & Delight
    Online Exclusives
    Association News
    Breaking News
    Financial News
    Industry News
    International
    Marketing News
    New Products
    News Front
    Packaging News
    Patents
    Personnel
    Regulations
    Snapshots
    Top News
    Live From Shows
    Top News
    Mix:Bar Launches at Target

    Crystal Deodorant Unveils Magnesium-Enriched Sticks

    Euromonitor Reveals Top 10 Global Consumer Trends for 2021

    A Surge in Interest for Supplements & Vitamins

    Gattefossé Launches Inspiration Collection
    Blog
    Online Exclusives
    Infographics
    Podcasts
    Whitepapers
    Videos
    Expert's Opinion
    HappiTV
    eBook
    Surveys
    International Top 30 Report
    Top 50 Report
    Top Companies
    44. Turtle Wax

    42. Spartan Chemical Company

    45. Spartan Chemical Company

    The Top 50

    49. Hain Celestial
    Actives
    Functional Ingredients
    Pigments
    Polymers
    Preservatives
    Surfactants

    A Surge in Interest for Supplements & Vitamins

    Honest, Refillable Cleaners

    Nailing It in 2020

    P&G, L'Oréal & Amorepacific Make News at CES

    PurposeBuilt Brands Files for IPO
    Air Care/Environmental Fragrance
    AP/Deo
    Color Cosmetics
    Disinfectants
    Fine Fragrance
    Hair Care
    Household Cleaning
    I&I Marketplace
    Laundry Care
    Oral Care
    OTC/Medicated
    Packaging
    Personal Cleansers
    Skin Care
    Sun Care
    Testing

    Mix:Bar Launches at Target

    Crystal Deodorant Unveils Magnesium-Enriched Sticks

    Euromonitor Reveals Top 10 Global Consumer Trends for 2021

    A Surge in Interest for Supplements & Vitamins

    Gattefossé Launches Inspiration Collection
    Lab Equipment
    Mixing
    Packaging
    Testing

    Three Form Vertical Beauty Alliance

    Logo Design Trends for 2021 & Beyond

    Coming Clean About Stink

    Henkel Reaches Sustainable Packaging Milestone

    Ross Designs Mixer for Increased Shear
    Contract Manufacturing / Private Label Directory
    Buyer's Guide
    Add New Company
    Corporate Profiles
    International Buyers Guide Companies
    Croda

    QRS (Quality Resourcing Services)

    KLK OLEO

    Centerchem Inc

    Jeen International
    Live From Shows
    Meetings
    Webinars
    Snapshots
    • Magazine
      • Current / Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Formulary
    • Directories
      • Buyer's Guide
      • Contract Manufacturing / Private Label Directory
      • Corporate Profiles
      • Add Your Company
    • Raw Materials
      • Actives
      • Functional Ingredients
      • Pigments
      • Polymers
      • Preservatives
      • Surfactants
    • End-User
      • Air Care/Environmental Fragrance
      • AP/Deo
      • Color Cosmetics
      • Disinfectants
      • Fine Fragrance
      • Hair Care
      • Household Cleaning
      • I&I Marketplace
      • Laundry Care
      • Oral Care
      • OTC/Medicated
      • Packaging
      • Personal Cleansers
      • Skin Care
      • Sun Care
      • Testing
    • Packaging
      • Lab Equipment
      • Mixing
      • Packaging
      • Testing
    • Top Companies
      • International Top 30 Report
      • Top 50 Report
    • Online Exclusives
    • Experts Opinion
    • Slideshows
    • HappiTV
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Blog
    • Whitepapers
    • Surveys
      • R & D Salary Survey
      • Sales & Marketing Salary Survey
    • Job Banks
    • Events
      • Industry Events
      • Live from show Events
      • Webinars
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    FDA Is Getting Personal

    Warning letters reiterate Agency priorities, target consumer reviews and trigger consumer class actions.

    FDA Is Getting Personal
    Related CONTENT
    • What You're Reading on Happi.com
    • Gal Gadot Is Revlon Spokeswoman
    • Beautycounter Backs Personal Care Products Safety Act
    • Unit Pack
    • We Need Good News And Better Research!
    Raqiyyah Pippins and Krithika Santhanam, Arnold & Porter Kaye Scholer LLP01.04.18
    By now, it is no secret that the Food and Drug Administration (FDA) is monitoring personal care product1 marketing and using warning letters to remind companies of what causes a product to be a drug in the United States. Since 2012, FDA has issued several warning letters highlighting its position that many popular claims promising anti-aging or other skin improvement benefits cause the products to be drugs under the Federal, Food, Drug & Cosmetic Act (FDCA).2 


    As a result, many personal care product companies already contemplate the risk of receiving an FDA warning letter when contemplating the risk profile for product claims. A review of FDA enforcement in 2017 indicates that companies should continue to do so. As detailed here, however, two other risks should also be considered: one, FDA’s scrutiny of consumer reviews, and two, an increase in demand letters from private litigants seeking recovery for alleged unapproved drug claims under state law.


    FDA Regulation in Personal Care


    As background, the past few years have been marked with an increase in scrutiny of personal care products by FDA, including FDA efforts to define the regulatory boundaries governing different classes of personal care products and clarify the regulatory distinction between cosmetics and drugs. After hinting to industry in 2011 that it intended to monitor the category, FDA issued a series of warning letters in 2012 emphasizing its concerns regarding the use of hair removal, ant-aging and blemish removal related claims for products labeled as cosmetics, asserting its position that such claims cross the “lines” for cosmetic products and cause such products to be drugs under the FDCA. From 2013 to 2016, FDA re-affirmed its position regarding the types of beautification claims that it considers to be drug claims, while also highlighting some new areas for consideration: specifically, the regulatory lines governing beautification devices, personal care products for diseased populations and third-party contractors.


    FDA’s classification of a personal care product matters because it can significantly impact the regulatory standards governing the product’s manufacturing, marketing and labeling.   Products classified as OTC drugs must either receive pre-market approval by FDA or conform to FDA monographs—essentially an FDA-approved formula for a drug product. In contrast, while cosmetic manufacturers are responsible for ensuring product safety, products classified as cosmetics do not need to obtain pre-market FDA approval or conform to a specified pre-approved FDA formula. 


    How FDA categorizes a personal care product is determined, in part, by what FDA concludes to be the manufacturer’s  “intended use” for the product. Among other things, FDA reviews product covers (e.g., advertisements, websites, labeling and ingredient statements) as evidence of a product’s intended use. Products marketed with drug claims, claims that a product is “intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or intended to affect the structure or any function of the body,” without pre-market approval by FDA or conforming to FDA monographs are considered “unapproved new drugs” and cannot be legally marketed in the US.4


    FDA Targets Consumer Reviews


    In previous years, claims that a personal care product affects the physical structure of the skin or provides recognized benefits commonly associated with drug products have been flagged as drug claims by FDA. This trend continued in 2017. FDA issued three warning letters alleging that claims to lighten or even skin tone, stimulate skin regeneration or “new skin cell production” or “promote cellular generation” are drug claims because they purportedly describe physiological effects on the structure or function of the body that are reserved for “drug” products under the FDCA.5  


    FDA also sent 10 warning letters to companies that touted recognized medicinal benefits for products labeled as cosmetics  (e.g., “antiviral,” “antimicrobial,” “anti-inflammatory,” “immunostimulant,” and “wound healing”).  For instance, in its July 2017 warning letter to Irie Star, LLC, FDA took the position that the company’s claim that the organic Tamanu oil in the Flawless - Equalizing Anti-Blemish Oil Serum is proven to have “antibacterial, anti-inflammatory and skin rebuilding properties” establishes the product containing the ingredient as an unapproved new drug under the FDCA “intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or articles intended to affect the structure or any function of the human body.”6 Similarly, FDA’s February 2017 warning letter to Aegeia Skin Care, LLC  alleged that claims that the chamomile flower in the company’s Nourishing Clay Mask has “anti-inflammatory properties” and can be used to “encourage digestion and boost the immune system,” cause the mask to be a drug.­­7  


    A new addition to FDA’s enforcement priorities, however, has been its focus on consumer reviews and testimonials. Because classification of a product as a “drug” vs. a “cosmetic” is centered on the manufacturer’s intended use for the product, there is, at times, a misconception that consumer reviews and testimonials present lower risk of FDA taking the position that a product is a drug.


    FDA’s December 2016 warning letter to Healthy Habits, LLC hinted that FDA may primarily rely on consumer reviews and testimonials as evidence that a personal care product is intended for use as a drug. According to FDA’s warning letter, Healthy Habits’ DermaTox ointment product page on the company website includes consumer testimonials touting that the product helped with “Diabetes related skin conditions,”  “severe shingles,” and “sunburns or any kind of burn.”  


    FDA’s 2017 warning letter to Moon Valley Natural Products reiterated FDA’s position on consumer reviews by including a section in the letter in which FDA specifically listed what it considered to be evidence of the manufacturer’s  intended use for its personal care products  “in the form of personal [consumer] testimonials recommending or describing the use of products for the cure, mitigation, treatment, or prevention of disease.”8


    These warning letters serve as a reminder that customer reviews and testimonials can play a material role in FDA’s position regarding a company’s intended use for a product and, as a result, companies should consider monitoring the testimonials and reviews on their product websites to determine whether they include claims that can trigger FDA enforcement or, as discussed below, class action litigation.


    Class Action Complaints


    Historically, many companies have made business decisions about whether to promote personal care products with claims that FDA may consider to be drug claims based on a belief that the only material risk associated with such use is an FDA warning letter. Recent class action litigation, however, indicates that the risk to the company is not limited to FDA enforcement.


    Importantly, each state has what is often referred to as a “mini-FDCA” that mirrors the FDCA and some state unfair and deceptive advertising practice (UDAP) statutes provide consumers with a private right of action to challenge the use of promotional strategies that violate the state’s mini-FDCA. In recent years, the plaintiffs’ bar has sought to recover damages from personal care product companies based on an allegation that FDA’s position that certain claims cause a personal care product to be an unapproved drug causes a product to violate the state’s UDAP statute. Indeed, within the past five years, dozens of class action complaints have been filed alleging that personal care product advertising is deceptive because it includes unapproved drug claims as defined by FDA warning letters issued to other companies that alleged that similar claim language constituted an unapproved drug claim.9


    For example, in March 2017, Revlon entered into a $900,000 settlement that involved allegations that the company’s products were marketed with unapproved drug claims.10   In pertinent part, plaintiffs alleged that “Revlon markets the Age Defying DNA Advantage Products as cosmetics . . . [b]ut the Age Defying DNA Advantage Products are also drugs because an intended use of the products, as repeatedly demonstrated throughout Revlon’s packaging, advertising and marketing materials, is to affect the structure and function of the human body, specifically, DNA with human skin.”11 After alleging that Revlon made unsupported representations that the products “Help[] protect skin’s DNA to fight signs of aging,” “Targets undereye puffiness, dark circles, fine lines and wrinkles,” and “[H]elps skin to feel conditioned and look luminous, minimizing the appearance of discoloration due to the signs of aging[,]”12 the plaintiffs further alleged that the company’s claims were deceptive under state law because they contained unapproved drug claims.  As support for their position, the plaintiffs cited a 2008 FDA Warning Letter to Natural Biology, Inc. in their complaint in which FDA alleged that products marketed with similar representations were unapproved new drugs.13


    Similarly, in December 2016, a lawsuit was filed against Sunday Riley Modern Skincare alleging that the company’s Bionic Anti-Aging cream was marketed with unapproved drug claims.14 In particular, the plaintiffs alleged that the product, which has not been approved by FDA to be marketed as a drug, was promoted with the alleged drug claims: “[l]oaded with active ingredients that help to extend the lifespan of your skin” and “Highly active CoQ10, transreveratrol, biopeptides, copper peptides, centella asiatica, + EGCG (from green tea) help support healthy collagen growth and fight the effects of skin aging caused by UV exposure.”15 


    According to the complaint, these claims purport that the product “functions as a skin-altering drug, not as a mere cosmetic” and serve to market the product “as if it were an FDA approved drug that could change the physical structure and function of skin itself.”16 


    What Does It Mean?


    The increased regulatory and litigation risk associated with FDA scrutiny of personal care products serves as an important reminder to companies that FDA is scrutinizing both claims made by companies and by consumers posted on the company website to determine the intended use for personal care products and that the implications of permitting a personal care product to be promoted with claims that FDA may consider to be reserved for drugs can extend beyond an FDA warning letter. 


    With this in mind, companies may want to consider expanding their marketing strategies to include a periodic review of the latest FDA warning letters to personal care product companies to stay abreast of the different types of claims considered by FDA to reflect intended drug uses and their hosted platforms to determine whether customer testimonials or reviews tout benefits that FDA has publicly deemed to reflect an intended drug use. 


    Taken together, these steps can help personal care product companies to more accurately assess the risk associated with a proposed marketing strategy and limit the risk that personal care product marketing will lead to unanticipated personal care product company liability. 


    About the Authors
    Raqiyyah Pippins is counsel and Krithika Santhanam is an associate with Arnold & Porter Kay Scholer, an international law firm based in Washington DC.  They may be reached at raqiyyah.pippins@apks.com, Tel: 202-942-6557 or krithika.santhanam@apks.com, Tel: 213-243-4217, respectively.
    More info: https://www.apks.com/

    References
    1. For the purposes of this article, “personal care product” is defined to include any product (including a device) that is topically applied to improve a person’s appearance.
    2. See e.g., FDA Warning Letter to Bioque Technologies, Inc (Oct. 7, 2016); FDA Warning Letter to Peter Thomas Roth Labs, LLC (July 22, 2016); FDA Warning Letter to Sircuit Cosmeceuticals (July 19, 2016); FDA Warning Letter to Annmarie Gianni Skin Care (July 15, 2016); FDA Warning Letter to Crescent Health Center, Inc. (April 20, 2016); and FDA Warning Letter to Cosmetic Dermatology, Inc. (Dec. 3, 2015).
    3. Color additives are the only cosmetic ingredients that must be pre-approved by FDA.
    4. FDCA section 505(a).
    5. See e.g., FDA Warning Letter to Be Natural Organics (July. 19, 2017); FDA Warning Letter to Cape Fear Naturals (March. 2, 2017); and FDA Warning Letter to Skin 2 Spirit, LLC (Aug. 10, 2017). 
    6. FDA Warning Letter to Irie Star, LLC (July 6, 2017).
    7. FDA Warning Letter to Aegeia Skin Care, LLC (Feb. 2, 2017).
    8. FDA Warning Letter to Moon Valley Natural Products LLC (Aug. 11,  2017).
    9. See e.g., Reid v. GMC Skin Care USA Inc., 2016 U.S. Dist. LEXIS 14001, at *30 (N.D.N.Y. 2016); Kimani Adams v. Reviva Labs, Inc., No. 1:15-cv-00495-GTS-DJS (N.D.N.Y. 2015); Geri Marshall v. PH Beauty Labs, Inc. No. 2:15-cv-02101-DDP-AGR (Cal. Super. Ct. 2015); and Constanza Nino v. L’Oreal USA, Inc. et al, No. 1:12-cv-23462-JLK (S.D. Fla. 2012).
    10. Elkind v. Revlon Consumer Prods. Corp., 2017 U.S. Dist. LEXIS 24512, at *8 (E.D.N.Y. 2017)
    11. Id. Complaint at 10-11.
    12. Id. Complaint at 11.
    13. Id. n.4.
    14. Class Action Complaint & Demand for Jury Trial, Helena Armstrong et al v. Sunday Riley Modern Skincare, LLC, No. 1:16-cv-09329 (S.D.N.Y. 2016).
    15. Id. Complaint at 3.
    16. Id. Complaint at 2, 10. 
    Related Searches
    • approved
    • personal
    • organic
    • skin
    Related Knowledge Center
    • Functional Ingredients
    • Hair Care
    • Skin Care
    Suggested For You
    What You What You're Reading on Happi.com
    Gal Gadot Is Revlon Spokeswoman Gal Gadot Is Revlon Spokeswoman
    Beautycounter Backs Personal Care Products Safety Act Beautycounter Backs Personal Care Products Safety Act
    Unit Pack Unit Pack
    We Need Good News And Better Research! We Need Good News And Better Research!
    FDA Rescinds Import-Alert 66-38 FDA Rescinds Import-Alert 66-38
    Scentsational Offerings Scentsational Offerings
    Revlon COO Steps Down Revlon COO Steps Down
    Q2 Sales Soar at Revlon Q2 Sales Soar at Revlon
    NYSCC’s Innovation in Textured Hair Care Event Is Oct. 12  NYSCC’s Innovation in Textured Hair Care Event Is Oct. 12
    Over-the-Counter (OTC) Monograph Reform Over-the-Counter (OTC) Monograph Reform
    Ramos Leaves Revlon To Become Chief Scientific Officer at Coty Ramos Leaves Revlon To Become Chief Scientific Officer at Coty
    Sen. Feinstein Speaks Out on Cosmetics Inspections Sen. Feinstein Speaks Out on Cosmetics Inspections
    ‘It’s a 10 Haircare’ Names New Senior VP ‘It’s a 10 Haircare’ Names New Senior VP
    FDA Issues Pair of Warning Letters FDA Issues Pair of Warning Letters

    Related Features

    • Color Cosmetics | Hair Care | Personal Cleansers | Skin Care
      Stepping into the Spotlight for 2021

      Stepping into the Spotlight for 2021

      A look at the leading indie brands in household and personal care for the new year.
      Melissa Meisel, Associate Editor 01.06.21

    • Color Cosmetics | Hair Care | Personal Cleansers | Skin Care | Sun Care
      The Independent Beauty Association Supports Sensible Reform

      The Independent Beauty Association Supports Sensible Reform

      What will the 117th Congress have in store for the cosmetics industry?
      Ken Marenus, Independent Beauty Association 01.06.21

    • Functional Ingredients | Laundry Care | Polymers | Surfactants
      A Clean Commitment

      A Clean Commitment

      In a pandemic, clean matters more than ever; which explains the gains in fabric care sales. A list of new ingredients follows the article.
      Tom Branna, Editorial Director 01.06.21


    • Disinfectants | Functional Ingredients | Household Cleaning | Laundry Care
      Deliver & Delight

      Deliver & Delight

      The fragrances used in home cleaning products must communicate clean, but increasingly health and wellness, too.
      Christine Esposito, Managing Editor 01.06.21

    • Color Cosmetics | Fine Fragrance | Hair Care | Personal Cleansers | Skin Care
      A Rebound for Beauty

      A Rebound for Beauty

      After a difficult year, the global cosmetics market is on the mend and will even exceed 2019 levels, according to predictions from McKinsey & Co.
      Tom Branna, Editorial Director 01.06.21

    • Hair Care | Skin Care
      Beauty Brands Must Prepare for a

      Beauty Brands Must Prepare for a 'Decade of the Home'

      The crisis will define consumption for the next decade, and it will force change for brands and companies more accustomed to catering to on-the-go consumers.
      Kim De Maeseneer, Accenture 01.06.21


    • Actives | Functional Ingredients | I&I Marketplace | Surfactants
      Front  & Center

      Front & Center

      The COVID-19 pandemic has moved commercial cleaning into the spotlight.
      Christine Esposito, Managing Editor 12.02.20

    • Functional Ingredients | Hair Care
      Clean-Label Shampoos with Xanthan Gum

      Clean-Label Shampoos with Xanthan Gum

      Thanks to its distinctive structure, xanthan gum provides a host of benefits when used as a thickener.
      Amirah Bajawi, Cameron Whitney and Dr. Teresa Berninger, Jungbunzlauer 12.02.20

    • Functional Ingredients | Hair Care | Polymers | Surfactants
      Just Hit Refresh

      Just Hit Refresh

      This year has been all about clean including advanced shampoo, conditioner and treatments for the scalp. A new ingredient list follows the article.
      Melissa Meisel , Associate Editor 12.02.20


    • Household Cleaning | Laundry Care | Personal Cleansers | Skin Care
      The Invention Legacy of COVID-19 & Implications for Home & Personal Care

      The Invention Legacy of COVID-19 & Implications for Home & Personal Care

      Recent inventions may reverse the course of COVID-19 and provide opportunities that could change the household and personal care industry.
      Robert and Margaret Lochhead, Lochhead Consulting LLC 12.02.20

    • Actives | OTC/Medicated | Skin Care
      Skin Care Actives  During  Inactivity

      Skin Care Actives During Inactivity

      When there’s nowhere to go, the focus is on the face.
      Tom Branna, Editorial Director 12.02.20

    • Fine Fragrance | Functional Ingredients
      This Stinks!

      This Stinks!

      The pandemic has been a plague on the fine fragrance industry; but the beauty industry is resilient and there are signs of a rebound.
      Tom Branna, Editorial Director 11.05.20


    • Actives | AP/Deo | Functional Ingredients | Personal Cleansers | Surfactants
      Me Time: The Market for Women

      Me Time: The Market for Women's Wellness

      While there is probably some slacking off due to social distancing, personal hygiene never goes out of style.
      Happi Staff 11.05.20

    • Actives | Personal Cleansers
      Lather Up for Long-Term Hand Hygiene for All

      Lather Up for Long-Term Hand Hygiene for All

      For Global Handwashing Day, October 15, several Henkel campaigns were aimed at improving compliance for everyone, but especially students.
      Martina Spinatsch, Henkel North America 11.05.20

    • Actives | Skin Care

      Rice-Derived Lactic Acid Bacteria Improves Skin Flora and Barrier

      Ichimaru Pharcos researchers detail the benefits of Fairy Flora K-1, which boosts the beneficial skin bacteria Coagulase-negative staphylococci.
      Kentaro Hirose and Arunasiri Iddamalgoda PhD , Ichimaru Pharcos Co.Ltd. 11.05.20

    Trending
    • Nu Skin Launches ‘Clean’ Formula Line
    • P&G, L'Oréal & Amorepacific Make News At CES
    • Formulating Liquid Laundry Detergents
    • Bad Habit Taps Global Brand Ambassador & Creative Director
    • Maybelline Unveils 'Sky High' Mascara
    Breaking News
    • Mix:Bar Launches at Target
    • Crystal Deodorant Unveils Magnesium-Enriched Sticks
    • Euromonitor Reveals Top 10 Global Consumer Trends for 2021
    • A Surge in Interest for Supplements & Vitamins
    • Gattefossé Launches Inspiration Collection
    View Breaking News >
    CURRENT ISSUE

    January 2021

    • Stepping into the Spotlight for 2021
    • The Independent Beauty Association Supports Sensible Reform
    • Essential Workers
    • A Clean Commitment
    • Deliver & Delight
    • Reusables for Consumables In the Pandemic and Beyond
    • A Rebound for Beauty
    • Beauty Brands Must Prepare for a 'Decade of the Home'
    • A Societal Shift
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise
    Qualitas Health/iwi Raises $10 Million in Investment Round
    Aker BioMarine Expands Krill Portfolio with Novel Protein Hydrolysate
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CHF Solutions Appoints CEO
    Freehand Partners with Imperial Medial Solutions
    Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
    NovaQuest Private Equity Acquires CoreRx
    JS Bio and Etta Biotech Advancing Partnership
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Marino Belotti Presents New Website
    Essence Cosmetics Expands in the U.S.
    Sigma Beauty Launches 'Brush Care' Sets at Sephora
    Happi

    Latest Breaking News From Happi

    Mix:Bar Launches at Target
    Crystal Deodorant Unveils Magnesium-Enriched Sticks
    Euromonitor Reveals Top 10 Global Consumer Trends for 2021
    Ink World

    Latest Breaking News From Ink World

    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Packaging Printing Market Worth $433.4 Billion by 2025: MarketsandMarkets
    O-I Foundation Gifts $50k to Facilitate COVID-19 Vaccine Access
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Honeywell Delivered 225 Million Masks in December
    Techtextil, Texprocess Postponed to 2022
    Super Strong Inks Survive Tough Environments
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Appoints SVP of Operations
    DePuy Synthes Receives 510(k) FDA Clearance for VELYS Robotic-Assisted Solution
    OrthoPediatrics Expands Agent Network in Three European Countries
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login